IGF1 and malignant colon neoplasm: Understanding how IGF-1, Wnt/β-catenin and p53 pathways regulate colon cancer cell kinetics may help in the development of new diagnostic markers, prognostic markers, therapeutic targets and/or evidence based safe chemotherapeutic strategies against IGF-1 promoted cancers.